Affinity Asset Advisors »

Aadi Bioscience shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Aadi Bioscience (AADI) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Aadi Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Aadi Bioscience held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aadi Bioscience by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $97k 47k 2.06
2023-06-30 $1.3M 188k 6.84

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Verona Pharma Sponsored Ads (VRNA)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nuvalent Inc-a (NUVL)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Vera Therapeutics Cl A (VERA)
Nurix Therapeutics (NRIX)

View all positions for Affinity Asset Advisors

Top funds holding Aadi Bioscience

venBio Select Advisor
QVT Financial
BML Capital Management
Longwood Capital Partners
Vanguard Group
Renaissance Technologies
Peapod Lane Capital
EcoR1 Capital
Soleus Capital Management
BlackRock
Geode Capital Management
Millennium Management
Bridgeway Capital Management
Northern Trust
Citadel Advisors

View all funds holding Aadi Bioscience